You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 4, 2024

Claims for Patent: 9,695,434


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,695,434
Title:Brassica plants yielding oils with a low alpha linolenic acid content
Abstract: Brassica plants producing oils with a low alpha-linolenic acid content and methods for producing such plants are described.
Inventor(s): Coonrod; Daren (Fort Collins, CO), Brandt; Kevin (Longmont, CO), Zheng; Honggang (Fort Collins, CO), Chen; Zhizheng (Fort Collins, CO), Fletcher; Richard (Windsor, CO)
Assignee: CARGILL, INCORPORATED (Wayzata, MN)
Application Number:13/685,588
Patent Claims:1. A Brassica plant comprising a modified allele at a fatty acid desaturase 3D (fad3D) locus, a fatty acid desaturase 3E (fad3E) locus, a fatty acid desaturase 3A (fad3A) locus and a fatty acid desaturase 3B (fad3B) locus wherein: (i) said modified allele results in the production of a FAD3 polypeptide having reduced desaturase activity relative to a corresponding wild-type FAD3 polypeptide; (ii) said fad3D locus has at least 90% identity to SEQ ID NO:32; (iii) said fad3E locus has at least 90% identity to SEQ ID NO:1; (iv) said fad3A locus comprises a nucleic acid selected from the group consisting of (a) a nucleic acid encoding a FAD3A polypeptide having a cysteine substituted for arginine at position 275 and (h) a nucleic acid encoding a truncated FAD3A polypeptide; (v) said fad3B locus comprises a nucleic acid selected from the group consisting of (a) a nucleic acid having a mutation in an exon-intron splice site recognition sequence and (b) a nucleic acid encoding a truncated FAD3B polypeptide and (vi) wherein said plant produces seeds yielding an oil having a stearic acid content of 0.95% to 3.9% and an alpha-linolenic acid (ALA) content of 0.5% to 1.95%.

2. The plant of claim 1, wherein said fad3D modified allele comprises a nucleic acid having a deletion of an exon or a portion thereof.

3. The plant of claim 2, wherein said deletion is in within exon 1 of said nucleic acid.

4. The plant of claim 1, wherein said fad3D modified allele comprises a nucleotide sequence having at least 95% sequence identity to the nucleic acid sequence set forth in SEQ ID NO:32.

5. The plant of claim 1, wherein said fad3E modified allele comprises a nucleic acid encoding a truncated FAD3E polypeptide.

6. The plant of claim 1, wherein said fad3E modified allele comprises a nucleic acid encoding a FAD3E polypeptide having a non-conservative substitution of a residue affecting substrate specificity.

7. The plant of claim 1, wherein said fad3E modified allele comprises a nucleic acid encoding a FAD3E polypeptide having a non-conservative substitution of a residue affecting catalytic activity.

8. The plant of claim 1, wherein said fad3E modified allele comprises a mutation in a splice donor site.

9. The plant of claim 1, wherein said fad3E modified allele comprises a nucleotide sequence having at least 95% sequence identity to the nucleotide sequence set forth in SEQ ID NO: 1.

10. The plant of claim 1, wherein said fad3D modified allele comprises a nucleic acid encoding a truncated FAD3D polypeptide.

11. The plant of claim 1, said plant producing seeds yielding an oil having an alpha-linolenic acid (ALA) content of less than 1.5%.

12. The plant of claim 1, said plant producing seeds yielding an oil having a stearic acid content of less than 2.5%.

13. The plant of claim 1, said plant further comprising a modified allele at a delta-12 fatty acid desaturase (fad2) locus, said fad2 modified allele comprising a nucleic acid selected from the group consisting of a nucleic acid encoding a FAD2 polypeptide having a lysine substituted for glutamic acid in a His-Glu-Cys-Gly-His motif (SEQ ID NO:26), a nucleic acid encoding a FAD2 polypeptide having a glutamic acid substituted for glycine in the DRDYGILNKV (SEQ ID NO:28) motif, and a nucleic acid encoding a FAD2 polypeptide having a histidine substituted for leucine in a KYLNNP motif (SEQ ID NO:27).

14. The plant of claim 1, said plant further comprising at least one modified allele at a fatty acyl-acyl-ACP thioesterase B (fatB) locus, wherein said fatB modified allele results in the production of a FATB polypeptide having reduced thioesterase activity relative to a corresponding wild-type FATB polypeptide.

15. The plant of claim 1, wherein said plant is a Brassica napus, Brassica juncea, or Brassica rapa plant.

16. The plant of claim 1, wherein said fad3D modified allele is a mutant allele.

17. Progeny of the plant of claim 1, said progeny comprising said modified alleles.

18. Progeny of the plant of claim 2, said progeny comprising said modified alleles.

19. Seeds of the plant of claim 1, wherein the seeds comprise said modified fad3D, fad3E, fad3A and fad3B alleles.

20. Seeds of the plant of claim 2, wherein the seeds comprise said modified fad3D, fad3E, fad3A and fad3B alleles.

21. A method of producing an oil, said method comprising: (a) crushing seeds produced from at least one Brassica plant of claim 1, said plant comprising said fad3D, fad3E, fad3A and fad3B modified alleles; and (b) extracting said oil from said crushed seeds, said oil having, after refining, bleaching, and deodorizing, a stearic acid content of 0.95% to 3.9%.

22. A method of making a Brassica plant line, said method comprising: (a) providing a population of plants; (b) identifying one or more plants in said population containing a modified allele at a fatty acid desaturase 3E (fad3E) locus, a fatty acid desaturase 3D (fad3D) locus, a fatty acid desaturase 3A (fad3A) locus or a fatty acid desaturase 3B (fad3B) locus wherein said modified allele results in the production of a FAD3E, FAD3D, FAD3A, or FAD3B polypeptide having reduced desaturase activity relative to a corresponding wild-type FAD3 polypeptide; (c) crossing one or more of said identified plants with itself or a different plant to produce seed; (d) crossing at least one progeny plant grown from said seed with itself or a different plant; and (e) repeating steps (c) and (d) for an additional 0-5 generations to make said plant line, wherein said modified allele at said fad3E locus, fad3D, fad3A and fad3B locus is present in said plant line, and wherein said plant line produces seeds yielding an oil having a stearic acid content of 0.95% to 3.9% and an alpha-linolenic acid (ALA) content of 0.5% to 1.95%.

23. The plant of claim 1, said plant further comprising a modified allele selected from the group consisting of a modified allele at a fatty acyl-acyl-ACP thioesterase A2 (fatA2) locus, wherein said fatA2 modified allele results in the production of a FATA2 polypeptide having reduced thioesterase activity relative to a corresponding wild-type FATA2 polypeptide, and a modified allele at a fatty acyl-acyl-ACP thioesterase B (fatB) locus, wherein said fatB modified allele results in the production of a FATB polypeptide having reduced thioesterase activity relative to a corresponding wild-type FATB polypeptide.

24. The plant of claim 11, said plant producing seeds yielding an oil having an alpha-linolenic acid (ALA) content of 0.6% to 1.5%.

25. The plant of claim 12, said plant producing seeds yielding an oil having a stearic acid content of 0.95% to 2.0%.

26. The plant of claim 1, said plant producing seeds yielding an oil having a stearic acid content of less than 2.5% and an alpha-linolenic acid (ALA) content of less than 1.5%.

27. The plant of claim 1, said plant producing seeds yielding an oil having an oleic acid content of at least 71% and no greater than 90%.

Details for Patent 9,695,434

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2030-05-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2030-05-25
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2030-05-25
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.